Related Experiment Videos

Child routines and youths' adherence to treatment for type 1 diabetes

Leilani Greening1, Laura Stoppelbein, Carlos Konishi

  • 1Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA. Lgreening@psychiatry.umsmed.edu

Journal of Pediatric Psychology
|October 13, 2006
PubMed

Insights

Establishing routines in children with type 1 diabetes (T1DM) can improve treatment adherence. This is particularly important for children with behavior problems, as routines help mediate the link between behavioral issues and adherence challenges.

Area of Science:

  • Pediatric Endocrinology
  • Child Psychology
  • Behavioral Medicine

Background:

  • Type 1 diabetes (T1DM) necessitates strict daily treatment adherence for survival.
  • Children with behavioral problems often struggle with T1DM treatment compliance, increasing health risks.
  • Childhood routines may influence treatment adherence in pediatric T1DM patients.

Purpose of the Study:

  • To empirically evaluate two theoretical models on the role of child routines in T1DM treatment adherence.
  • To test if child routines moderate or mediate the relationship between behavior problems and adherence in T1DM.
  • To understand the psychological processes underlying routine behavior's impact on T1DM management.

Main Methods:

  • Parents of 111 children (ages 6-16) with T1DM completed standardized measures for behavior problems, routines, and treatment adherence.
  • Statistical procedures by Baron and Kenny were employed to test moderation and mediation hypotheses.
  • Regression analyses were conducted to evaluate the proposed theoretical models.

Main Results:

  • The study did not support the moderation hypothesis.
  • Results supported the mediation hypothesis, indicating child routines mediate the link between behavior problems and T1DM treatment adherence.
  • Engaging in daily routines was found to be a significant factor in adherence for children with T1DM.

Conclusions:

  • Instilling daily routines in children with T1DM, especially those with behavioral challenges, is recommended to enhance treatment adherence.
  • Increased adherence through routines can potentially reduce morbidity and mortality risks associated with T1DM.
  • Findings have implications for developing targeted clinical interventions for pediatric T1DM management.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...